Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Operating Income Performance
Above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$205.42M
↑ 248% above average
Average (9y)
$59.00M
Historical baseline
Range
High:$205.42M
Low:$-8.62M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $205.42M | +4.3% |
| 2023 | $196.99M | +83.2% |
| 2022 | $107.50M | +53.8% |
| 2021 | $69.89M | +538.0% |
| 2020 | $10.95M | +28187.2% |
| 2019 | $-39000.00 | +99.5% |
| 2018 | $-8.62M | -863.5% |
| 2017 | $-895000.00 | -105.7% |
| 2016 | $15.69M | +327.5% |
| 2015 | $-6.90M | - |